DICE Therapeutics, Inc. (DICE) Ownership

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$47.46
Day's range
$47.83

DICE Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 08/14/2023 7.86 M $365.02 M   0.00% 16.65%
BLACKROCK INC. 08/11/2023 2.90 M $134.52 M   -3.89% 6.14%
FMR LLC 08/11/2023 2.24 M $104.03 M   -60.58% 4.74%
AVORO CAPITAL ADVISORS LLC 08/14/2023 2.20 M $102.18 M   -44.32% 4.66%
ALPINE ASSOCIATES MANAGEMENT INC. 08/10/2023 2.12 M $98.35 M   100.00% 4.49%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2023 2.04 M $94.70 M   1.83% 4.32%
VANGUARD GROUP INC 08/14/2023 1.96 M $90.94 M   1.51% 4.15%
MAGNETAR FINANCIAL LLC 08/11/2023 1.16 M $53.70 M   100.00% 2.45%
PENTWATER CAPITAL MANAGEMENT LP 08/14/2023 1.08 M $50.20 M   100.00% 2.29%
UBS OCONNOR LLC 02/14/2024 1.08 M $49.94 M   100.00% 2.28%
BAKER BROS. ADVISORS LP 08/14/2023 1.04 M $48.12 M   0.00% 2.19%
BRAIDWELL LP 08/14/2023 1.03 M $47.85 M   4.58% 2.18%
WESTCHESTER CAPITAL MANAGEMENT, LLC 08/14/2023 978.89 K $45.48 M   100.00% 2.07%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2023 913.94 K $42.46 M   100.00% 1.94%
KRYGER CAPITAL LTD 08/10/2023 880.76 K $40.92 M   100.00% 1.87%
STATE STREET CORP 08/14/2023 835.91 K $38.84 M   4.71% 1.77%
GEODE CAPITAL MANAGEMENT, LLC 08/11/2023 743.34 K $34.54 M   6.81% 1.58%
NEXPOINT ASSET MANAGEMENT, L.P. 08/14/2023 717.32 K $33.33 M   100.00% 1.52%
GOLDMAN SACHS GROUP INC 05/14/2024 707.04 K $32.85 M   348.58% 1.50%
JPMORGAN CHASE & CO 08/11/2023 618.09 K $28.72 M   1,233.32% 1.31%
MORGAN STANLEY 08/14/2023 599.47 K $27.85 M   672.14% 1.27%
MILLENNIUM MANAGEMENT LLC 08/14/2023 560.36 K $26.03 M   106.34% 1.19%
ALLIANCEBERNSTEIN L.P. 08/15/2023 551.65 K $25.63 M   1,618.53% 1.17%
WATER ISLAND CAPITAL LLC 11/14/2024 483.89 K $22.48 M   100.00% 1.03%
VERSOR INVESTMENTS LP 08/07/2023 436.94 K $20.30 M   4,269.35% 0.93%
SAND GROVE CAPITAL MANAGEMENT LLP 08/11/2023 422.36 K $19.62 M   100.00% 0.90%
NICHOLAS INVESTMENT PARTNERS, LP 08/10/2023 416.15 K $19.33 M   0.00% 0.88%
ARROWMARK COLORADO HOLDINGS LLC 08/14/2023 410.80 K $19.09 M   -0.34% 0.87%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 08/11/2023 403.00 K $18.72 M   100.00% 0.85%
UBS GROUP AG 08/11/2023 399.28 K $18.55 M   2,373.27% 0.85%
NEW LEAF VENTURE PARTNERS, L.L.C. 08/10/2023 371.69 K $17.27 M   0.00% 0.79%
PICTON MAHONEY ASSET MANAGEMENT 08/03/2023 370.00 K $17.19 M   100.00% 0.78%
HSBC HOLDINGS PLC 08/11/2023 367.13 K $17.00 M   100.00% 0.78%
NORTHERN TRUST CORP 08/11/2023 346.26 K $16.09 M   12.06% 0.73%
AQR ARBITRAGE LLC 08/14/2023 341.88 K $15.88 M   100.00% 0.72%
D. E. SHAW & CO., INC. 08/14/2023 323.45 K $15.03 M   -41.85% 0.69%
OUP MANAGEMENT CO., LLC 08/07/2023 268.35 K $12.47 M   0.00% 0.57%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/10/2023 265.76 K $12.35 M   4.00% 0.56%
FIRST TRUST CAPITAL MANAGEMENT L.P. 08/14/2023 250.00 K $11.62 M   100.00% 0.53%
NUVEEN ASSET MANAGEMENT, LLC 08/16/2023 224.25 K $10.42 M   70.63% 0.48%
CAPULA MANAGEMENT LTD 08/14/2023 213.80 K $9.93 M   100.00% 0.45%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2023 212.70 K $9.88 M   100.00% 0.45%
VOYA INVESTMENT MANAGEMENT LLC 02/07/2025 210.07 K $9.76 M   153.38% 0.45%
SAMSARA BIOCAPITAL, LLC 08/14/2023 202.77 K $9.42 M   0.00% 0.43%
SEGANTII CAPITAL MANAGEMENT LTD 08/02/2023 200.00 K $9.29 M   100.00% 0.42%
GABELLI FUNDS LLC 08/10/2023 186.90 K $8.68 M   100.00% 0.40%
CRABEL CAPITAL MANAGEMENT, LLC 08/14/2023 161.08 K $7.48 M   100.00% 0.34%
LMR PARTNERS LLP 08/14/2023 151.70 K $7.05 M   100.00% 0.32%
VERITION FUND MANAGEMENT LLC 08/14/2023 148.40 K $6.89 M   100.00% 0.31%
ERGOTELES LLC 08/14/2023 146.76 K $6.82 M   440.71% 0.31%

DICE Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 10 institutional investors and hedge funds held shares of DICE Therapeutics, Inc.. The most heavily invested institutionals were:

Ergoteles LLC: 0

OUP Management Co., LLC: 0

Quantamental Technologies LLC: 0

INNOVIS ASSET MANAGEMENT LLC: 0

PICTET ASSET MANAGEMENT SA: 17,570

Private Capital Group, LLC: 89

96.64% of DICE Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 292.66 K shares in the last 24 months. This purchase volume represents approximately $13.92 M in transactions.